慣性聚合 高效追蹤和閱讀你感興趣的部落格、新聞、科技資訊
閱讀原文 在慣性聚合中打開

推薦訂閱源

小众软件
小众软件
博客园 - 叶小钗
有赞技术团队
有赞技术团队
大猫的无限游戏
大猫的无限游戏
博客园_首页
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
L
LangChain Blog
Hugging Face - Blog
Hugging Face - Blog
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
aimingoo的专栏
aimingoo的专栏
Blog — PlanetScale
Blog — PlanetScale
爱范儿
爱范儿
T
Tailwind CSS Blog
Jina AI
Jina AI
量子位
Stack Overflow Blog
Stack Overflow Blog
人人都是产品经理
人人都是产品经理
J
Java Code Geeks
V
Visual Studio Blog
月光博客
月光博客

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem CuriosityStream: AI Is Not Enough For An Investment Here Akamai Collapse: Did Anthropic Just Kill Its Prospects? I Think Not Potential $5,000 Monthly Income - 12 Investments To Buy And Hold For The Next 10 Years Citizens Financial Group: Q1 Results Should Validate Recent Strength Weekly Indicators: The Consumer Continues To Spend Like There's No Tomorrow Don't Overlook Arthur J. Gallagher & Co. When Investing Global Ship Lease: Embedded Upside From Charter Repricing And Trade Disruption Marvell: Rating Upgrade On Data Center Boom EMCOR Group: Solid Business That Is Fully Valued High-Yield REITs I Would Trust For Retirement Income Rubrik's Growth Engines Are Working, But 18% Dilution Risk Weighs On The Upside Coeur Mining: The Market Is Still Pricing The Old CDE Morgan Stanley Direct Lending Has Some Issues, But The Price Makes It Buyable Exploring Digital Equity With These 3 Stocks Twin Disc's Pop Means It's Time For A Downgrade Peloton: Great Improvements But With An Idea Lacking Evidence Tap The Brakes And Buy SPLV Clean Up Your Portfolio With Bath & Body Works Devon-Coterra Merger: Good And Bad Tyson Foods: Pivoting Beyond Cyclicality Into Structural Growth
Cytokinetics公司(CYTK)股東/分析師電話會議準備發言記錄
2026-05-28 · via All Articles on Seeking Alpha

Cytokinetics, Incorporated (CYTK) 股東/分析師電話會議 2026年5月27日 下午1:00 EDT

公司參與者

Diane Weiser - 企業事務高級副總裁
John Henderson
Jeffrey Hessekiel - 執行副總裁、首席法律與行政官
羅伯特·I·布魯姆(Robert I. Blum) - 執行長、總裁 兼 董事

簡報

黛安·韋瑟(Diane Weiser)
企業事務資深副總裁

歡迎各位女士和先生參加賽托凱尼克斯(Cytokinetics)2026年股東年度會議。我是黛安·韋瑟(Diane Weiser),企業事務資深副總裁。現在,我想通知您,本次會議正在錄音。[操作員指示]。

我現在將會議交給董事會主席約翰·亨德森(John Henderson)。請開始。

約翰·亨德森

非常感謝,黛安(Diane)。歡迎各位女士、先生。我是約翰·亨德森(John Henderson),Cytokinetics(細胞動力學)董事會主席,歡迎各位參加我們2026年度股東大會。會議現在正式開始。

在進入正式議程之前,讓我介紹公司總裁兼執行長羅伯特·布魯姆(Robert Blum)。羅伯特將在正式會議結束後,回顧我們2025年的成就以及2026年的計劃。

此外,我很榮幸地介紹今天與我們同在的Cytokinetics董事會其他成員:Muna Bhanji(穆娜·班吉)、Jim Daly(吉姆·達利)、Robert Harrington(羅伯特·哈靈頓)、Ed Kaye(艾德·凱)、Bob Landry(鮑勃·蘭德里)、Wendell Wierenga(溫德爾·維倫加)和Nancy Wysenski(南希·維森斯基)。我也很榮幸地介紹今天親自出席的公司企業指導委員會其他成員:Andrew Callos(安德魯·卡洛斯),執行副總裁兼首席商務官;Isaac Ciechanover(艾薩克·西查諾弗),企業發展執行副總裁兼首席業務官;Steve Cook(史蒂夫·庫克),全球供應鏈與技術運營高級副總裁;YulyMae DiNapoli(尤莉梅·迪納波利),人力資源高級副總裁;Jeff Hessekiel(傑夫·赫塞基爾),執行副總裁、首席法務與行政官;Sung Lee(李成),執行副總裁兼首席財務官;Fady Malik(法迪·馬利克),研發執行副總裁;以及Christine Murray(克莉絲汀·穆雷),全球監管事務高級副總裁。我也想介紹安永(Ernst)的Dan Coleman(丹·科爾曼)。& Young有限责任合夥(Young LLP),該公司的獨立註冊公共會計師事務所,並且他可供